Related Experiment Video
Updated: Apr 28, 2026

08:14
Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
Published on: October 28, 2014
12.4K
Inhibiting HDAC for human hematopoietic stem cell expansion
The Journal of Clinical Investigation
|June 4, 2014
Summary
Researchers expanded hematopoietic stem cells (HSCs) from human cord blood (CB) ex vivo. This novel epigenetic modification protocol shows potential for clinical applications in regenerative medicine.
Area of Science:
- Hematology
- Epigenetics
- Stem Cell Biology
Background:
- Hematopoietic stem cells (HSCs) are crucial for blood formation and are found in cord blood (CB).
- Ex vivo expansion of HSCs is challenging but essential for therapeutic applications.
- Epigenetics, the study of heritable gene expression changes without altering DNA sequence, is a rapidly advancing field.
Purpose of the Study:
- To develop an effective protocol for ex vivo expansion of human cord blood HSCs.
- To investigate the role of epigenetic modifications in enhancing HSC expansion.
- To assess the potential clinical applicability of the developed expansion protocol.
Main Methods:
- Utilized a combination of cytokines and specific epigenetic modifications.
- Applied the protocol to human cord blood HSCs for ex vivo expansion.
- Compared the expansion efficiency with previous methods.
Main Results:
- Achieved impressive ex vivo expansion of HSCs from human cord blood.
- Demonstrated that altering epigenetic modifications enhances HSC expansion.
- The protocol represents a significant advancement over prior techniques.
Conclusions:
- The developed protocol offers a promising strategy for expanding cord blood HSCs ex vivo.
- This method has potential for clinical consideration in regenerative medicine and transplantation.
- The study highlights the importance of epigenetics in stem cell expansion.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K

